Results 111 to 120 of about 7,662 (208)

Pharmacokinetic modeling and simulation support for age- and weight-adjusted dosing of dabigatran etexilate in children with venous thromboembolism. [PDF]

open access: yesJ Thromb Haemost, 2021
Röshammar D   +14 more
europepmc   +1 more source

Nutrition and prevention of venous thromboembolism [PDF]

open access: yes, 2012
Prophylaxis of venous thromboembolism is a major health problem in everyday clinical practice. The therapeutic anticoagulants available to clinicians for prophylaxis of VTE is mainly composed by parenteral anticoagulants and oral vitamin K antagonists ...
Mattioli, AV, Pennella, S
core  

P4600Prescribing of dabigatran etexilate in accordance with the European label for stroke prevention in atrial fibrillation: Findings from the GLORIA-AF Registry [PDF]

open access: bronze, 2017
G Y H Lip   +11 more
openalex   +1 more source

Prothrombin complex concentrates reduce blood loss in murine coagulopathy induced by warfarin, but not in that induced by dabigatran etexilate [PDF]

open access: bronze, 2012
Melissa D. Lambourne   +5 more
openalex   +1 more source

Off-target effects of oral anticoagulants - vascular effects of vitamin K antagonist and non-vitamin K antagonist oral anticoagulant dabigatran etexilate. [PDF]

open access: yesJ Thromb Haemost, 2021
van Gorp RH   +14 more
europepmc   +1 more source

Presente y futuro del tratamiento anticoagulante oral [PDF]

open access: yes, 2014
The alternative new oral anticoagulants open a new era in antithrombotic treatment. For more than half a century, vitamin K antagonists have defined oral anticoagulant therapy for the long-term management of thrombotic disorders.
García Frade, Luis Javier
core   +1 more source

216-71: Reduction of recurrence of atrial fibrillation after electrical cardioversion by Dabigatran-etexilate [PDF]

open access: bronze, 2016
Christian Obst   +3 more
openalex   +1 more source

Home - About - Disclaimer - Privacy